Stockreport

TG Therapeutics: The Cloud Over Briumvi [Seeking Alpha]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF Initial sales of TG Therapeutics' anti-CD20 MS treatment Briumvi were solid, generating $92 million in FY23, with expectations of over $260 million in FY24. TG Therap [Read more]